articleNature MedicineSep 21, 2003Closed access

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

Indiana University – Purdue University Indianapolis · Indiana University School of Medicine · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

669
total citations
FWCI
12.49
Percentile
100%
References
27
Citations per year

Authors

4

Topics & keywords

Keywords
  • Nephronophthisis
  • Polycystic kidney disease
  • Medicine
  • Internal medicine
  • Vasopressin
  • Endocrinology
  • Autosomal Recessive Polycystic Kidney Disease
  • Disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding